Tom Stargardt
YOU?
Author Swipe
View article: Cost-utility analysis of 177Lu-PSMA-617 radioligand therapy in second-line and third-line treatment for metastatic castration-resistant prostate cancer (mCRPC) in Germany
Cost-utility analysis of 177Lu-PSMA-617 radioligand therapy in second-line and third-line treatment for metastatic castration-resistant prostate cancer (mCRPC) in Germany Open
View article: Does timing matter? The role of health information shocks in measuring willingness to pay
Does timing matter? The role of health information shocks in measuring willingness to pay Open
Objectives The optimal point in time to measure willingness-to-pay (WTP) remains unclear. We investigated the role of health information shocks (HIS) in individuals’ WTP, analyzing the extent to which news of SARS-CoV-2 infections among pe…
View article: Understanding health risk perception: insights from an eight-country panel study during the COVID-19 pandemic
Understanding health risk perception: insights from an eight-country panel study during the COVID-19 pandemic Open
Aim The COVID-19 pandemic highlighted the importance of individuals’ risk perceptions and their impact on behaviour. Adequate risk perceptions help individuals adopt necessary precautions. Subject and methods We conducted a longitudinal pa…
View article: Harmonizing regulatory market approval of products with high safety requirements: Evidence from the European pharmaceutical market
Harmonizing regulatory market approval of products with high safety requirements: Evidence from the European pharmaceutical market Open
We causally analyzed whether being a member of the European Union (EU) and having access to a centralized marketing authorization procedure (centralized procedure [CP]) affects availability and time to launch of new pharmaceuticals. We emp…
View article: From Health to Well-Being: Toward a Monetary Valuation of a Well-Being-Adjusted Life-Year
From Health to Well-Being: Toward a Monetary Valuation of a Well-Being-Adjusted Life-Year Open
Despite the inherent limitations of our study, it offers valuable insights into methods for eliciting the WTP for changes in capability well-being as measured with ICECAP-A.
View article: To merge or not to merge? The impact of mergers and acquisitions on corporate success in the pharmaceutical industry
To merge or not to merge? The impact of mergers and acquisitions on corporate success in the pharmaceutical industry Open
Two of the chief goals of most companies are to secure their own existence and generate above‐average returns for their owners. One of the main ways that companies attempt to achieve these goals is to grow, and pharmaceutical companies are…
View article: N02 Inflammatory bowel disease patients with impaired quality of life on biologic therapy benefit from the support of an IBD nurse specialist: Results of a randomized controlled trial in Germany (IBDBIO-ASSIST study) - The IBD nurses perspective
N02 Inflammatory bowel disease patients with impaired quality of life on biologic therapy benefit from the support of an IBD nurse specialist: Results of a randomized controlled trial in Germany (IBDBIO-ASSIST study) - The IBD nurses perspective Open
Background IBD nurses play an important role in the Multidisciplinary Team of managing patients with IBD. IBDBIO-ASSIST was a randomised controlled trial assessing the efficacy of care provided by an IBD nurse specialist in improving healt…
View article: Authors’ Reply to Gandjour: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?”
Authors’ Reply to Gandjour: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?” Open
View article: Socioeconomic Disparities In Mortality And Health Care Use During The COVID-19 Pandemic: Evidence From Germany
Socioeconomic Disparities In Mortality And Health Care Use During The COVID-19 Pandemic: Evidence From Germany Open
Across the globe, populations with low socioeconomic status have borne a disproportionate burden of the COVID-19 pandemic. This article examines the relationship between two socioeconomic factors (education and income) and all-cause mortal…
View article: Correction: Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic
Correction: Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic Open
View article: Vaccine hesitancy comes in waves: Longitudinal evidence on willingness to vaccinate against COVID-19 from seven European countries
Vaccine hesitancy comes in waves: Longitudinal evidence on willingness to vaccinate against COVID-19 from seven European countries Open
View article: Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic
Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic Open
View article: Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease
Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease Open
View article: Cooperation Improvement in an Integrated Healthcare Network: A Social Network Analysis
Cooperation Improvement in an Integrated Healthcare Network: A Social Network Analysis Open
Background: Cooperation is a core feature of integrated healthcare systems and an important link in their value-creating mechanism. The premise is that providers who cooperate can promote more efficient use of health services while improvi…
View article: Treatment patterns of individualized real-life tapering approaches based on shared decision-making in rheumatoid arthritis
Treatment patterns of individualized real-life tapering approaches based on shared decision-making in rheumatoid arthritis Open
View article: Jumping the Queue:Willingness to Pay for Faster Access to COVID-19 Vaccines in Seven European Countries
Jumping the Queue:Willingness to Pay for Faster Access to COVID-19 Vaccines in Seven European Countries Open
We find that most respondents would have been willing to pay for faster access to COVID vaccines (jumping the queue), suggesting welfare gains from quicker access to these vaccines. This is an important result in light of potential future …
View article: Does health technology assessment compromise access to pharmaceuticals?
Does health technology assessment compromise access to pharmaceuticals? Open
In response to rapidly rising pharmaceutical costs, many countries have introduced health technology assessment (HTA) as a ‘fourth hurdle’. We evaluated the causal effect of HTA based regulation on access to pharmaceuticals by using the in…
View article: 10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany? Open
View article: Health-related quality of life in seven European countries throughout the course of the COVID-19 pandemic: evidence from the European COvid Survey (ECOS)
Health-related quality of life in seven European countries throughout the course of the COVID-19 pandemic: evidence from the European COvid Survey (ECOS) Open
View article: Vaccine Hesitancy Comes in Waves: Longitudinal Evidence on Willingness to Vaccinate Against COVID-19 from Seven European Countries
Vaccine Hesitancy Comes in Waves: Longitudinal Evidence on Willingness to Vaccinate Against COVID-19 from Seven European Countries Open
View article: Changes in launch delay and availability of pharmaceuticals in 30 European markets over the past two decades
Changes in launch delay and availability of pharmaceuticals in 30 European markets over the past two decades Open
Background The timing of the launch of a new drug is an important factor that determines access for patients. We evaluated patient access to pharmaceuticals in 30 European markets over the past two decades. Methods Launch dates were extrac…
View article: Patient expectations do matter - Experimental evidence on antibiotic prescribing decisions among hospital-based physicians
Patient expectations do matter - Experimental evidence on antibiotic prescribing decisions among hospital-based physicians Open
View article: Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients Open
Although FDC therapy increased disease-specific pharmaceutical spending in the short term, this increase did not lead to differences in total healthcare costs from the payer perspective. From the patient perspective, FDC therapy may be the…
View article: Depression and anxiety in later COVID-19 waves across Europe: New evidence from the European COvid Survey (ECOS)
Depression and anxiety in later COVID-19 waves across Europe: New evidence from the European COvid Survey (ECOS) Open
View article: An econometric approach to aggregating multiple cardiovascular outcomes in German hospitals
An econometric approach to aggregating multiple cardiovascular outcomes in German hospitals Open
View article: Psychometric evaluation of the Mental Health Quality of Life (MHQoL) instrument in seven European countries
Psychometric evaluation of the Mental Health Quality of Life (MHQoL) instrument in seven European countries Open
View article: Does health technology assessment compromise access to pharmaceuticals?
Does health technology assessment compromise access to pharmaceuticals? Open
View article: Effectiveness of a home telemonitoring program for patients with chronic obstructive pulmonary disease in Germany: Evidence from the first three years
Effectiveness of a home telemonitoring program for patients with chronic obstructive pulmonary disease in Germany: Evidence from the first three years Open
Introduction Chronic obstructive pulmonary disease (COPD) affects more than 6 million people in Germany. Monitoring the vital parameters of COPD patients remotely through telemonitoring may help doctors and patients prevent and treat acute…
View article: Prevalence and determinants of probable depression and anxiety during the COVID-19 pandemic in seven countries: Longitudinal evidence from the European COvid Survey (ECOS)
Prevalence and determinants of probable depression and anxiety during the COVID-19 pandemic in seven countries: Longitudinal evidence from the European COvid Survey (ECOS) Open
View article: Regimen simplification and medication adherence: Fixed-dose versus loose-dose combination therapy for type 2 diabetes
Regimen simplification and medication adherence: Fixed-dose versus loose-dose combination therapy for type 2 diabetes Open
Background Suboptimal patient adherence to pharmacological therapy of type 2 diabetes may be due in part to pill burden. One way to reduce pill burden in patients who need multiple medications is to use fixed-dose combinations. Our study a…